Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors
Enhancing Management of Patient Reported Outcomes With Emotion Regulation (EMPOWER)
5 other identifiers
interventional
43
1 country
2
Brief Summary
This pilot clinical trial studies how well an internet-delivered positive affect (PA) intervention works in managing emotion in young adult cancer survivors. An internet-delivered PA intervention may teach younger cancer survivors healthy coping skills and help doctors to learn more about what effects mood may have on the health and well-being of young adults with cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2016
CompletedFirst Posted
Study publicly available on registry
July 14, 2016
CompletedStudy Start
First participant enrolled
April 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2020
CompletedResults Posted
Study results publicly available
July 16, 2020
CompletedJuly 16, 2020
July 1, 2020
2 years
May 20, 2016
May 13, 2020
July 6, 2020
Conditions
Outcome Measures
Primary Outcomes (10)
Acceptability - Mean Value
Quantitative measures and interview will be used to quantify acceptability. The mean of participants responding affirmatively to the highest two responses from an intervention evaluation phone interview script created by investigators will be combined and exact 95% confidence intervals (CIs) will be calculated for these estimates. Participants were asked the following questions: On a scale of 0 to 10, with 0 being definitely not to 10 being definitely yes, to what extent would you recommend these skills to a friend? and To what extent would you recommend this intervention to someone newly diagnosed with cancer?
At 12 weeks
Acceptability - Proportion Value
Quantitative measures and interview will be used to quantify acceptability. The proportion of participants responding affirmatively to the highest two responses from an intervention evaluation phone interview script created by investigators will be combined and exact 95% confidence intervals (CIs) will be calculated for these estimates. Responding affirmatively means a score of 9 or 10 on the scale of 0-10, so the proportion responding affirmatively is the proportion of patients who responded with a 9 or 10 to those questions. Participants were asked the following questions: On a scale of 0 to 10, with 0 being definitely not to 10 being definitely yes, to what extent would you recommend these skills to a friend? and To what extent would you recommend this intervention to someone newly diagnosed with cancer?
At 12 weeks
Accrual
Accrual will be estimated as the number of patients accrued divided by the number of months of accrual. A 95% confidence interval for the monthly accrual rate will be calculated based on the Poisson distribution.
Up to 19 months
Adherence - Proportion of Completed Interventions (Mean Value)
Adherence to the intervention will be calculated as the number of intervention sessions completed. Investigators will calculate and report the mean adherence across all individuals who completed three or more sessions.
At 12 weeks
Adherence - Proportion of Completed Interventions (Proportion Value)
Adherence to the intervention will be calculated as the number of intervention sessions completed. Investigators will calculate and report the proportion of patients who completed three or more sessions.
At 12 weeks
Number of Patients Who Refused to Participate
The refusal rate will be estimated as the number of patients who refuse to participate divided by the number eligible.
At 12 weeks
Number of Patient Provided Data at 8 Weeks - Retention
Retention will be defined as the proportion of patients who provide 8 week data. Patients who discontinue the intervention (refuse phone calls) but complete the outcome assessments will be counted in the numerator for calculating retention. Retention estimates will be calculated overall and by site
At 8 week
Adherence - Number of Completed Exercises
Adherence to the intervention will be calculated as the frequency of completing exercises. Investigators will calculate and report the mean adherence across all individuals as well as the proportion of patients who completed three or more sessions.
At 12 weeks
Number of Website Visits
Adherence to the intervention will be calculated as the number of website visits. Investigators will calculate and report the mean adherence across all individuals as well as the proportion of patients who completed three or more sessions.
At 12 weeks
Number of Patients Provided Data at 12 Weeks - Retention
Retention will be defined as the number of patients who provide 12 week data. Patients who discontinue the intervention (refuse phone calls) but complete the outcome assessments will be counted in the numerator for calculating retention.
At 12 weeks
Study Arms (1)
Supportive Care
EXPERIMENTALPatients complete an initial online questionnaire lasting about 25-30 minutes. Patients complete an internet-delivered PA program during weeks 3-8. Each week consists of didactic material and 20-30 minutes of daily online exercises.
Interventions
Ancillary studies
Eligibility Criteria
You may qualify if:
- Able to read and understand English
- Past history of a cancer diagnosis (excluding basal cell skin carcinoma)
- to 39 years of age at diagnosis
- Within 0-5 years post-active treatment
- Wireless internet connection or a home computer that is connected to the internet
You may not qualify if:
- Evidence of a cancer recurrence
- History of multiple primary cancers
- Currently receiving palliative or hospice care
- Significant psychiatric history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wake Forest University Health Scienceslead
- National Cancer Institute (NCI)collaborator
- National Institute of Mental Health (NIMH)collaborator
Study Sites (2)
Northwestern University
Chicago, Illinois, 60611, United States
Comprehensive Cancer Center of Wake Forest University
Winston-Salem, North Carolina, 27157, United States
Related Publications (2)
Salsman JM, McLouth LE, Tooze JA, Little-Greene D, Cohn M, Kehoe MS, Moskowitz JT. An eHealth, Positive Emotion Skills Intervention for Enhancing Psychological Well-Being in Young Adult Cancer Survivors: Results from a Multi-Site, Pilot Feasibility Trial. Int J Behav Med. 2023 Oct;30(5):639-650. doi: 10.1007/s12529-023-10162-5. Epub 2023 Mar 8.
PMID: 36890329DERIVEDSalsman JM, McLouth LE, Cohn M, Tooze JA, Sorkin M, Moskowitz JT. A Web-Based, Positive Emotion Skills Intervention for Enhancing Posttreatment Psychological Well-Being in Young Adult Cancer Survivors (EMPOWER): Protocol for a Single-Arm Feasibility Trial. JMIR Res Protoc. 2020 May 28;9(5):e17078. doi: 10.2196/17078.
PMID: 32463014DERIVED
Results Point of Contact
- Title
- Study coordinator
- Organization
- Wake Forest University Health Sciences
Study Officials
- PRINCIPAL INVESTIGATOR
John Salsman
Wake Forest University Health Sciences
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2016
First Posted
July 14, 2016
Study Start
April 21, 2017
Primary Completion
April 23, 2019
Study Completion
April 23, 2020
Last Updated
July 16, 2020
Results First Posted
July 16, 2020
Record last verified: 2020-07